Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibers
Adam J. Davenport, Ioana Berindan‐Neagoe, Nico Bräuer, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Brain aging mechanisms with mechanical manifestations
Yana Blinkouskaya, Andreia Caçoilo, Trisha Gollamudi, et al.
Mechanisms of Ageing and Development (2021) Vol. 200, pp. 111575-111575
Open Access | Times Cited: 156
The importance of sulfur-containing motifs in drug design and discovery
Muhamad Mustafa, Jean‐Yves Winum
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 5, pp. 501-512
Closed Access | Times Cited: 123
The Complexity of Neuropathic Pain and Central Sensitization: Exploring Mechanisms and Therapeutic Prospects
Yan-chao Ma, Ze-biao Kang, Yongqiang Shi, et al.
Journal of Integrative Neuroscience (2024) Vol. 23, Iss. 5
Open Access | Times Cited: 12
The P2X3 receptor antagonist filapixant in patients with refractory chronic cough: a randomized controlled trial
Christian Friedrich, Klaus Francke, Surinder S. Birring, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 22
Efficacy and Safety of Eliapixant in Refractory Chronic Cough: The Randomized, Placebo-Controlled Phase 2b PAGANINI Study
Peter V. Dicpinigaitis, Alyn H. Morice, John A. Smith, et al.
Lung (2023) Vol. 201, Iss. 3, pp. 255-266
Open Access | Times Cited: 22
Neurogenic Inflammation in the Context of Endometriosis—What Do We Know?
Renata Voltolini Velho, Eliane T. Taube, Jalid Sehouli, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 13102-13102
Open Access | Times Cited: 37
Benefit-Risk Profile of P2X3 Receptor Antagonists for Treatment of Chronic Cough
Shota Yamamoto, Nobuyuki Horita, Johsuke Hara, et al.
CHEST Journal (2024) Vol. 166, Iss. 5, pp. 1124-1140
Closed Access | Times Cited: 4
Diabetic neuropathy: cutting-edge research and future directions
Yang Yang, Bing Zhao, Yuanzhe Wang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Safety, Pharmacodynamics, and Pharmacokinetics of P2X3 Receptor Antagonist Eliapixant (BAY 1817080) in Healthy Subjects: Double-Blind Randomized Study
Christian Friedrich, Klaus Francke, Isabella Gashaw, et al.
Clinical Pharmacokinetics (2022) Vol. 61, Iss. 8, pp. 1143-1156
Open Access | Times Cited: 18
ATP, an attractive target for the treatment of refractory chronic cough
Mengru Zhang, Dominic L. Sykes, Laura R. Sadofsky, et al.
Purinergic Signalling (2022) Vol. 18, Iss. 3, pp. 289-305
Open Access | Times Cited: 18
Discovery of Triazolopyrimidine Derivatives as Selective P2X3 Receptor Antagonists Binding to an Unprecedented Allosteric Site as Evidenced by Cryo-Electron Microscopy
Garam Kim, Subin Kim, Yeo Ok Kim, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 16, pp. 14443-14465
Closed Access | Times Cited: 3
Probiotic-mediated p38 MAPK immune signaling prolongs the survival of Caenorhabditis elegans exposed to pathogenic bacteria
Miroslav Dinić, Stefan Jakovljević, Jelena Đokić, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 23
The Role of Microglial Purinergic Receptors in Pain Signaling
Hidetoshi Tozaki‐Saitoh, Hiroshi Takeda, Kazuhide Inoue
Molecules (2022) Vol. 27, Iss. 6, pp. 1919-1919
Open Access | Times Cited: 16
AI-based prediction of new binding site and virtual screening for the discovery of novel P2X3 receptor antagonists
Koon Mook Kang, Ingoo Lee, Hojung Nam, et al.
European Journal of Medicinal Chemistry (2022) Vol. 240, pp. 114556-114556
Closed Access | Times Cited: 13
Neurotrophins and Their Receptors, Novel Therapeutic Targets for Pelvic Pain in Endometriosis, Are Coordinately Regulated by IL-1β via the JNK Signaling Pathway
Jie Yu, Sarah L. Berga, Eric Zou, et al.
American Journal Of Pathology (2023) Vol. 193, Iss. 8, pp. 1046-1058
Open Access | Times Cited: 7
P2X3 and P2X2/3 Receptors Inhibition Produces a Consistent Analgesic Efficacy: A Systematic Review and Meta-Analysis of Preclinical Studies
Miguel Á. Huerta, Daniel Marcos-Frutos, Javier de la Nava, et al.
European Journal of Pharmacology (2024) Vol. 984, pp. 177052-177052
Open Access | Times Cited: 2
Potential applications of P2X3 receptor antagonists in the treatment of refractory cough
Baiyi Yi, Shengyuan Wang, Wanzhen Li, et al.
Respiratory Medicine (2023) Vol. 217, pp. 107336-107336
Closed Access | Times Cited: 6
Efficacy and Safety of Eliapixant in Overactive Bladder: The 12-Week, Randomised, Placebo-controlled Phase 2a OVADER Study
Flavio Ewerton, Francisco Cruz, M Kapp, et al.
European Urology Focus (2023) Vol. 10, Iss. 1, pp. 90-97
Closed Access | Times Cited: 6
Laser-induced deposition of copper from deep eutectic solvents: optimization of chemical and physical parameters
Andrey Shishov, Dmitry Gordeychuk, Lev Logunov, et al.
New Journal of Chemistry (2021) Vol. 45, Iss. 46, pp. 21896-21904
Closed Access | Times Cited: 13
Roles of extracellular adenosine triphosphate on the functions of periodontal ligament cells
Maythwe Kyawsoewin, Jeeranan Manokawinchoke, Worachat Namangkalakul, et al.
BDJ Open (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Validation of an artificial intelligence solution for acute triage and rule-out normal of non-contrast CT head scans
T. A. Dyer, Sanjiv Chawda, Raed Alkilani, et al.
Neuroradiology (2021) Vol. 64, Iss. 4, pp. 735-743
Closed Access | Times Cited: 11
The Unmet Needs for Studying Chronic Pelvic/Visceral Pain Using Animal Models
Ana Catarina Neto, Mariana Santos-Pereira, Pedro Abreu‐Mendes, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 696-696
Open Access | Times Cited: 4
Efficacy and safety of eliapixant in diabetic neuropathic pain and prediction of placebo responders with an exploratory novel algorithm: results from the randomized controlled phase 2a PUCCINI study
Didier Bouhassira, Solomon Tesfaye, Arnab Sarkar, et al.
Pain (2023)
Closed Access | Times Cited: 4
Molecular insights into P2X signalling cascades in acute kidney injury
Swati Mishra, Vishwadeep Shelke, Neha Dagar, et al.
Purinergic Signalling (2024) Vol. 20, Iss. 5, pp. 477-486
Open Access | Times Cited: 1
Non-coding RNAs in diabetic peripheral neuropathy: their role and mechanisms underlying their effects
Yiqian He, Ling Qu
Metabolism (2024) Vol. 154, pp. 155833-155833
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top